Cutter & CO Brokerage, Inc. Provectus Biopharmaceuticals, Inc. Transaction History

Cutter & CO Brokerage, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$0.05 - $0.06 $1,487 - $1,785	-29,750 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$0.06 - $0.08 $225 - $300	3,750 Added 14.42%	29,750 $2,000
Q2 2020 Aug 10, 2020	BUY	$0.04 - $0.06 $1,040 - $1,560	26,000 New	26,000 $1,000
Q4 2018 Feb 07, 2019	SELL	$0.05 - $0.08 $1,425 - $2,280	-28,500 Closed	0 $0
Q3 2018 Oct 12, 2018	BUY	$0.06 - $0.08 $1,710 - $2,280	28,500 New	28,500 $2,000

229K

Ticker PVCT
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 419,496,992
Market Cap $41.9M
Description
Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. It develops PV-10, an investigational autolytic cancer immunotherapy for adult solid tumor cancers, such as melanoma and gastrointestinal tumors, including hepatocellular carcinoma; colorectal ...

Get notified when there are updates to the investment portfolio of Cutter & CO Brokerage, Inc., based on Form 13F filings with the SEC.

Stay updated on Cutter & CO Brokerage, Inc. with notifications on news.